Vincent Haufroid

9.9k total citations · 1 hit paper
204 papers, 6.9k citations indexed

About

Vincent Haufroid is a scholar working on Health, Toxicology and Mutagenesis, Pediatrics, Perinatology and Child Health and Transplantation. According to data from OpenAlex, Vincent Haufroid has authored 204 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Health, Toxicology and Mutagenesis, 43 papers in Pediatrics, Perinatology and Child Health and 36 papers in Transplantation. Recurrent topics in Vincent Haufroid's work include Pharmacological Effects and Toxicity Studies (39 papers), Heavy Metal Exposure and Toxicity (38 papers) and Renal Transplantation Outcomes and Treatments (36 papers). Vincent Haufroid is often cited by papers focused on Pharmacological Effects and Toxicity Studies (39 papers), Heavy Metal Exposure and Toxicity (38 papers) and Renal Transplantation Outcomes and Treatments (36 papers). Vincent Haufroid collaborates with scholars based in Belgium, France and Netherlands. Vincent Haufroid's co-authors include Dominique Lison, Pierre Wallemacq, Laure Elens, Michel Mourad, Martine De Meyer, Peter Hoet, Benoît Nemery, Philippe Hantson, Teun van Gelder and Arnaud Capron and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Vincent Haufroid

194 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sustainability of artisanal mining of cobalt in DR Congo

2018 350 citations Vincent Haufroid et al. profile →

Peers

Countries citing papers authored by Vincent Haufroid

Since Specialization

Citations

This map shows the geographic impact of Vincent Haufroid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Haufroid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Haufroid more than expected).

Fields of papers citing papers by Vincent Haufroid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Haufroid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Haufroid. The network helps show where Vincent Haufroid may publish in the future.

Co-authorship network of co-authors of Vincent Haufroid

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Haufroid. A scholar is included among the top collaborators of Vincent Haufroid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Haufroid. Vincent Haufroid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanomedicine-enhanced SCAP hybrid spheroids: A novel approach for improved stem cell survival 2025 ·International Journal of Pharmaceutics ·(unknown), Bernard Učakar, Kévin Vanvarenberg, (unknown), Vincent Haufroid, (unknown), Anne des Rieux	0
2	An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress 2025 ·Circulation ·Lauriane Y. M. Michel, Hrag Esfahani, (unknown), (unknown), Jérôme Ambroise, Véronique Roelants, Brigitte Bouchard, (unknown), (unknown), Joseph P. Dewulf, (unknown), Caroline Bouzin, Vincent Haufroid, Joost J.F.P. Luiken, Miranda Nabben, Michael L. Singleton, Luc Bertrand, Matthieu Ruiz, Christine Des Rosiers, Jean‐Luc Balligand	3
3	Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study 2025 ·The Journal of Infectious Diseases ·Julien De Greef, Jean Cyr Yombi, Anne Vincent, Bernard E. Van Beers, Philippe de Timary, (unknown), (unknown), Nadtha Panin, Laure Elens, Vincent Haufroid, Leïla Belkhir	1
4	Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19 2024 ·Transplant International ·(unknown), (unknown), Caroline Monchaud, (unknown), (unknown), (unknown), Lionel Couzi, Olivier Thaunat, Laure Esposito, Magdalena Meszaros, (unknown), Vincent Haufroid, Yannick Le Meur, F. Lemaı̂tre	5
5	Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant 2024 ·Frontiers in Pharmacology ·Amy de Haar-Holleman, (unknown), (unknown), (unknown), Stéphane Steurbaut, Freya Vaeyens, Vincent Haufroid	1
6	Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives 2024 ·Clinical Chemistry ·(unknown), Maria Stoenoiu, Vincent Haufroid, Marilucy Lopez‐Sublet, (unknown), (unknown), Christophe Beauloye, Dominique Maiter, Andrzej Januszewicz, Reinhold Kreutz, Alexandre Persu, Damien Gruson	4
7	Can we identify patients carrying targeted deleterious DPYD variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Manon Launay, Laure Raymond, Jérôme Guitton, Marie‐Anne Loriot, Étienne Chatelut, Vincent Haufroid, Fabienne Thomas, Marie-Christine Etienne-Grimaldi	0
8	Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1 2023 ·Microbiome ·(unknown), Vincent Haufroid, Axelle Loriot, Laurent Gatto, Vanessa Andries, Lars Vereecke, Laure Elens, Laure B. Bindels	35
9	Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross‐Sectional Study 2023 ·Clinical Pharmacology & Therapeutics ·(unknown), Laure B. Bindels, Vincent Haufroid, (unknown), (unknown), (unknown), Joseph P. Dewulf, Djamila Chaïb Eddour, Michel Mourad, Laure Elens	12
10	Quantitative impact of pre‐analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency 2022 ·British Journal of Clinical Pharmacology ·(unknown), Manon Launay, Bernard Royer, Jérôme Guitton, Elodie Gautier‐Veyret, Sophie Broutin, Camille Tron, (unknown), Joseph Ciccolini, Damien Richard, (unknown), Vincent Haufroid, (unknown), Antonin Schmitt, Marie-Christine Étienne-Grimaldi, Céline Narjoz, Fabienne Thomas, (unknown)	15
11	Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation 2021 ·Annals of Oncology ·Fabienne Thomas, (unknown), Manon Launay, Camille Tron, Marie-Christine Étienne-Grimaldi, Elodie Gautier‐Veyret, Vincent Haufroid, Nicolas Pallet, Bernard Royer, Céline Narjoz, Antonin Schmitt	11
12	Intentional acetylsalicylic acid acute intoxication and its clinical management 2019 ·SHILAP Revista de lepidopterología ·Reza Soleimani, (unknown), Julien Favresse, Vincent Haufroid, Damien Gruson, Philippe Hantson, Pierre Wallemacq	3
13	Absence of genotoxic impact assessed by micronucleus frequency in circulating lymphocytes of workers exposed to cadmium 2018 ·Toxicology Letters ·Dominique Lison, G. Van Maele‐Fabry, Anne Vral, S. Vermeulen, Philippe Bastin, Vincent Haufroid, Ans Baeyens	3
14	A Simultaneous D‐Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation 2011 ·The Journal of Clinical Pharmacology ·Flora T. Musuamba, Michel Mourad, Vincent Haufroid, (unknown), Arnaud Capron, Isabelle Delattre, (unknown), Pierre Wallemacq, Roger K. Verbeeck	35
15	Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference 2009 ·Therapeutic Drug Monitoring ·Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet, Vincent Haufroid, David W. Holt, A. E. Johnston, Dirk Kuypers, Yannick Le Meur, Pierre Marquet, Michael Oellerich, Éric Thervet, (unknown), N. Undre, Lutz T. Weber, Ian S Westley, Michel Mourad	362
16	Cyp3a5 and Abcb1 Polymorphisms Influence Tacrolimus Concentrations in Peripheral Blood Mononuclear Cells in Renal Transplant Patients 2009 ·Transplant International ·Arnaud Capron, Michel Mourad, Vincent Haufroid, Pierre Wallemacq	1
17	The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function 2006 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Michel Mourad, Pierre Wallemacq, Martine De Meyer, (unknown), (unknown), Jacques Malaise, Djamila Chaïb Eddour, Dominique Lison, Vincent Haufroid	50
18	Urinary cotinine as a tobacco-smoke exposure index: a minireview 1998 ·International Archives of Occupational and Environmental Health ·Vincent Haufroid, Dominique Lison	218
19	Biological monitoring of workers exposed to low levels of 2-butoxyethanol 1997 ·International Archives of Occupational and Environmental Health ·Vincent Haufroid, (unknown), Pascal Mertens, (unknown), Dominique Lison	22
20	Toxicologie Industrielle et Intoxications Professionnelles 1982 ·CERN Document Server (European Organization for Nuclear Research) ·R. Lauwerys, Vincent Haufroid, Peter Hoet, Dominique Lison	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact